An­no­vis Bio claims wins in Alzheimer's and Parkin­son's, shares sky­rock­et; FDA de­lays de­ci­sion for Omeros' nar­so­plimab

A Berwyn, PA-based biotech is claim­ing a huge win in both Alzheimer’s and Parkin­son’s dis­eases, and it’s send­ing their shares sky­rock­et­ing.

An­no­vis Bio re­port­ed re­sults …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER